Physician profile
Ryan Bruns
NPI 1215793146
$1,750.22
in general payments reported to CMS, 2019-2025
21 companies · $1,470 in 2025
The $1,470 reported for 2025 was more than what 92% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $280 · 2025: $1,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,651.22 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $430.75 | 2025 | |
| Janssen Biotech, INC. | $202.46 | 2025 | Tremfya, Simponi, Simponi Aria |
| Madrigal Pharmaceuticals | $168.63 | 2024-2025 | Rezdiffra, Resmetirom |
| Aimmune Therapeutics, INC. | $153.33 | 2024-2025 | Zenpep |
| Ardelyx, INC. | $124.87 | 2024-2025 | Ibsrela |
| Lilly USA, LLC | $104.24 | 2024-2025 | Omvoh |
| Takeda Pharmaceuticals U.S.A., INC. | $88.66 | 2024-2025 | Eohilia, Entyvio, Gattex |
| Genzyme Corporation | $74.88 | 2025 | |
| Redhill Biopharma INC. | $64.50 | 2024-2025 | Talicia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.14 | 2025 | Xifaxan |
| Gilead Sciences, INC. | $50.26 | 2025 | |
| Novo Nordisk INC | $40.55 | 2025 | Wegovy |
| Qol Medical, LLC | $37.59 | 2024-2025 | Sucraid, Sucraid |
| Regeneron Healthcare Solutions, INC. | $31.63 | 2025 | Dupixent |
| Pfizer INC. | $27.96 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22.61 | 2024 | Injectafer |
| Evoke Pharma, INC. | $17.75 | 2024 | |
| Phadia US INC. | $16.91 | 2024 | Immunocap |
| Exact Sciences Corporation | $16.13 | 2024 | Cologuard Collection Kit |
| Celltrion USA INC. | $14.53 | 2024 | Vegzelma |
| Organon LLC | $10.84 | 2025 | Hadlima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bruns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.